Creative Financial Designs Inc. ADV Has $812,000 Stock Position in Aflac Incorporated (NYSE:AFL)

Creative Financial Designs Inc. ADV grew its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 420.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,266 shares of the financial services provider's stock after purchasing an additional 5,870 shares during the quarter. Creative Financial Designs Inc. ADV's holdings in Aflac were worth $812,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Strategic Financial Concepts LLC increased its holdings in shares of Aflac by 7,001.0% during the 2nd quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider's stock worth $596,000 after acquiring an additional 658,303 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of Aflac by 10,878.5% during the 3rd quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider's stock worth $62,597,000 after acquiring an additional 554,803 shares during the last quarter. Truist Financial Corp increased its holdings in shares of Aflac by 26.6% during the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider's stock worth $172,338,000 after acquiring an additional 405,847 shares during the last quarter. Swedbank AB acquired a new position in shares of Aflac during the 1st quarter worth approximately $27,588,000. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider's stock worth $429,319,000 after acquiring an additional 285,576 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Wells Fargo & Company boosted their target price on Aflac from $90.00 to $106.00 and gave the stock an "equal weight" rating in a report on Thursday, October 10th. JPMorgan Chase & Co. upped their price objective on Aflac from $85.00 to $90.00 and gave the company a "neutral" rating in a report on Thursday, October 3rd. Barclays started coverage on Aflac in a report on Wednesday, September 4th. They issued an "underweight" rating and a $96.00 price objective on the stock. Evercore ISI upped their price objective on Aflac from $84.00 to $90.00 and gave the company an "underperform" rating in a report on Thursday, September 26th. Finally, Bank of America upped their price objective on Aflac from $115.00 to $124.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $97.87.

Insider Buying and Selling

In related news, Director Thomas J. Kenny sold 2,000 shares of the company's stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the transaction, the director now directly owns 18,158 shares in the company, valued at $1,796,552.52. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.90% of the stock is owned by corporate insiders.

Aflac Price Performance

Shares of NYSE:AFL traded down $0.08 during midday trading on Friday, hitting $104.71. The stock had a trading volume of 2,823,181 shares, compared to its average volume of 2,237,747. The company's 50-day moving average price is $110.52 and its 200-day moving average price is $97.80. The company has a market capitalization of $58.64 billion, a P/E ratio of 15.77, a price-to-earnings-growth ratio of 2.24 and a beta of 0.95. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to analysts' expectations of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.51%. The business's revenue for the quarter was down 40.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.84 EPS. As a group, equities research analysts predict that Aflac Incorporated will post 6.83 EPS for the current fiscal year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date is Wednesday, November 20th. Aflac's dividend payout ratio is 30.12%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.